Related Experiment Video
Updated: Jul 7, 2026

Quantification of Oculomotor Responses and Accommodation Through Instrumentation and Analysis Toolboxes
Published on: March 3, 2023
The convergence insufficiency treatment trial: design, methods, and baseline data
1Pennsylvania College of Optometry, 1200 West Godfrey Ave, Philadelphia, PA 19141, USA. mscheiman@pco.edu
Insights
The Convergence Insufficiency Treatment Trial (CITT) established a robust methodology for evaluating treatments for convergence insufficiency in children. Baseline data from 221 children were collected to define the clinical profile of participants.
Area of Science:
- Ophthalmology
- Pediatric Optometry
- Clinical Trial Design
Background:
- Convergence insufficiency (CI) is a common binocular vision disorder affecting children.
- Previous treatment evaluations lacked large-scale, placebo-controlled, randomized clinical trial designs.
Purpose of the Study:
- To describe the design and methodology of the Convergence Insufficiency Treatment Trial (CITT).
- To report the clinical and demographic characteristics of children enrolled in the CITT.
Main Methods:
- Prospective randomization of children aged 9-17 into four treatment groups: home-based pencil push-ups, home-based computer therapy, office-based therapy with home reinforcement, and office-based placebo.
- Outcome measures included the Convergence Insufficiency Symptom Survey (CISS) score, near point of convergence (NPC), and positive fusional vergence.
- Data collected at baseline, 12 weeks post-treatment, and 6 and 12 months post-treatment.
Main Results:
- The CITT enrolled 221 children with symptomatic CI, mean age 12.0 years.
- Baseline clinical profile: 9Δ exophoria at near, 2Δ exophoria at distance, CISS score 30, NPC 14 cm, near positive fusional vergence break 13Δ.
- No significant baseline differences observed between the four treatment groups.
Conclusions:
- The CITT employed rigorous design features: formal outcome definitions, standardized protocols, placebo arm, masked examinations, and CISS score.
- The reported baseline data characterize the cohort for this pivotal CI study.
Objective:
This report describes the design and methodology of the Convergence Insufficiency Treatment Trial (CITT), the first large-scale, placebo-controlled, randomized clinical trial evaluating treatments for convergence insufficiency (CI) in children. We also report the clinical and demographic characteristics of patients.
Methods:
We prospectively randomized children 9 to 17 years of age to one of four treatment groups: 1) home-based pencil push-ups, 2) home-based computer vergence/accommodative therapy and pencil push-ups, 3) office-based vergence/accommodative therapy with home reinforcement, 4) office-based placebo therapy. Outcome data on the Convergence Insufficiency Symptom Survey (CISS) score (primary outcome), near point of convergence (NPC), and positive fusional vergence were collected after 12 weeks of active treatment and again at 6 and 12 months posttreatment.
Results:
The CITT enrolled 221 children with symptomatic CI with a mean age of 12.0 years (SD = +2.3). The clinical profile of the cohort at baseline was 9Delta exophoria at near (+/- 4.4) and 2Delta exophoria (+/-2.8) at distance, CISS score = 30 (+/-9.0), NPC = 14 cm (+/- 7.5), and near positive fusional vergence break = 13 Delta (+/- 4.6). There were no statistically significant nor clinically relevant differences between treatment groups with respect to baseline characteristics (p > 0.05).
Conclusion:
Hallmark features of the study design include formal definitions of conditions and outcomes, standardized diagnostic and treatment protocols, a placebo treatment arm, masked outcome examinations, and the CISS score outcome measure. The baseline data reported herein define the clinical profile of those enrolled into the CITT.
Related Concept Videos
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Comparison Tests
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
